Regulatory Affairs Professionals Society· @RAPSorg · X·· 2 小时前精选AI 评分40
AI 导读
FDA 处方药推广办公室（OPDP）向 Evolus 发出无标题函，指其在 Instagram 上夸大药物 Jeuveau 的疗效宣称，并模糊处方药与消费品化妆品之间的界限。该函件为 FDA 针对处方药推广的执法行动，链接为 https://hubs.la/Q04zg8tF0。
推荐理由
FDA 处方药推广办公室对 Evolus 发出无标题函，涉及疗效宣称夸大与处方药和消费品边界模糊，可了解监管对社媒推广的执法口径。
正文
FDA Office of Prescription Drug Promotion has issued an untitled letter to Evolus for exaggerating efficacy claims for its drug Jeuveau and for “blurring the lines” between prescription products and consumer cosmetics on Instagram.
https://hubs.la/Q04zg8tF0
来源：Regulatory Affairs Professionals Society · x.com